 Desvenlafaxine Succinate
"Desvenlafaxine Succinate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cyclohexanol and phenol derivative and metabolite of venlafaxine that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT.
| Descriptor ID |
D000069468
|
| MeSH Number(s) |
D02.033.415.510.500.303 D02.455.426.392.368.367.318.500 D02.455.426.559.389.657.265 D10.289.510.500.303
|
| Concept/Terms |
Desvenlafaxine Succinate- Desvenlafaxine Succinate
- Succinate, Desvenlafaxine
- O-desmethylvenlafaxine Succinate Monohydrate
- Monohydrate, O-desmethylvenlafaxine Succinate
- O desmethylvenlafaxine Succinate Monohydrate
- Succinate Monohydrate, O-desmethylvenlafaxine
- 2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate
- O-desmethylvenlafaxine Succinate
- O desmethylvenlafaxine Succinate
- Succinate, O-desmethylvenlafaxine
WY 45,233- WY 45,233
- 45,233, WY
- WY-45,233
- WY45,233
- WY-45233
- WY45233
- WY 45233
- 45233, WY
Desvenlafaxine- Desvenlafaxine
- O-desmethylvenlafaxine
- O desmethylvenlafaxine
- 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
|
Below are MeSH descriptors whose meaning is more general than "Desvenlafaxine Succinate".
Below are MeSH descriptors whose meaning is more specific than "Desvenlafaxine Succinate".
This graph shows the total number of publications written about "Desvenlafaxine Succinate" by people in this website by year, and whether "Desvenlafaxine Succinate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Desvenlafaxine Succinate" by people in Profiles.
-
Men X, Taylor ZL, Marshe VS, Blumberger DM, Karp JF, Kennedy JL, Lenze EJ, Reynolds CF, Stefan C, Mulsant BH, Ramsey LB, M?ller DJ. CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clin Pharmacol Ther. 2024 May; 115(5):1065-1074.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|